How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance
Maximus (MMS) reported Q3 2026 revenue of $1.28B and net income of $103.59M. It updated 2026 guidance to revenue of $5.2B-$5.35B and net income of $376M-$392M. Management emphasized disciplined acquisitions and share repurchases within a 2x-3x net debt ratio. The company expects 4.7% yearly revenue growth and $458.8M earnings by 2029, according to its narrative.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise expectations for revenue growth and margin expansion.
Market read
Fresh earnings and guidance provide a new trading catalyst for MMS.
What to watch
Potential volume swings and renewal risk in large U.S. contracts.
Background
Maximus is a provider of outsourced health and human services to U.S. governments.
Ticker impact
Maximus reported Q3 2026 results: $1.279B revenue, $103.6M net income and raised full‑year guidance to $5.2‑$5.35B revenue, $376‑$392M net income.
Potential short‑term rally of 3‑5% as investors price in stronger outlook.
The fresh earnings numbers and higher guidance are material for a mid‑cap government services contractor.
Market effects
May lift other government‑services and health‑outsourcing stocks.
Positive for U.S. defense and health‑care outsourcing sector.
Limited to U.S. markets; no direct global macro effect.
Counterpoint
Guidance still modest; budget constraints could pressure future contracts.
Key entities
- CompanyMaximus, Inc.
Government services contractor.


